BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27063266)

  • 1. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis.
    Kanwar P; Kowdley KV
    Clin Liver Dis; 2016 May; 20(2):225-43. PubMed ID: 27063266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease as a multi-systemic disease.
    Fotbolcu H; Zorlu E
    World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
    J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.
    Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L
    Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Kelley CE; Brown AJ; Diehl AM; Setji TL
    World J Gastroenterol; 2014 Oct; 20(39):14172-84. PubMed ID: 25339805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A; Wong RJ; Harrison SA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of metabolic factors for nonalcoholic Fatty liver disease in women.
    Chung GE; Yim JY; Kim D; Lim SH; Yang JI; Kim YS; Yang SY; Kwak MS; Kim JS; Cho SH
    Biomed Res Int; 2015; 2015():131528. PubMed ID: 25973422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Clanton J; Subichin M
    Surg Clin North Am; 2016 Aug; 96(4):703-15. PubMed ID: 27473796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
    Carr RM; Oranu A; Khungar V
    Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?].
    Roeb E
    Zentralbl Chir; 2014 Apr; 139(2):168-74. PubMed ID: 22441997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Buzzetti E; Pinzani M; Tsochatzis EA
    Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Targher G; Byrne CD
    Metab Syndr Relat Disord; 2015 Aug; 13(6):235-8. PubMed ID: 25714786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.